narmafotinib   Click here for help

GtoPdb Ligand ID: 12373

Synonyms: AMP-945 | AMP945 | CTX-0294945 | example 3 [US9120761B2]
Compound class: Synthetic organic
Comment: We mapped the chemical structure for the INN narmafotinib, via PubChem, to the research code AMP-945. AMP-945 is a focal adhesion kinase (FAK) inhibitor that was developed for anti-tumour potential [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 93.37
Molecular weight 527.25
XLogP 3.51
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc(ccc1Nc1ncc(c(n1)CCc1ccccc1CC(=O)N)C(F)(F)F)C1CCN(CC1)C
Isomeric SMILES CN1CCC(CC1)c1cc(c(cc1)Nc1ncc(c(n1)CCc1ccccc1CC(=O)N)C(F)(F)F)OC
InChI InChI=1S/C28H32F3N5O2/c1-36-13-11-19(12-14-36)21-8-10-24(25(15-21)38-2)35-27-33-17-22(28(29,30)31)23(34-27)9-7-18-5-3-4-6-20(18)16-26(32)37/h3-6,8,10,15,17,19H,7,9,11-14,16H2,1-2H3,(H2,32,37)(H,33,34,35)
InChI Key AWJVIOYPZZZYAX-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
AMP945 has progressed to early stage clinical evaluation.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05355298 AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer Phase 1/Phase 2 Interventional Amplia Therapeutics Limited